Glory Health Industry Limited (HKG:2329)
Hong Kong · Delayed Price · Currency is HKD 0.0950
+0.0070 (7.95%)
Jul 31, 2026, 4:08 PM HKT
Glory Health Industry Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 422 | 564 | 453 | 142 | 1,156 | 1,356 | |
Market Cap Growth | -49.47% | 24.51% | 218.75% | -87.69% | -14.75% | -60.39% |
Enterprise Value | 29,539 | 27,943 | 26,815 | 26,117 | 28,015 | 29,185 |
Last Close Price | 0.10 | 0.13 | 0.10 | 0.03 | 0.26 | 0.30 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 4.84 |
PS Ratio | 0.37 | 0.49 | 0.16 | 0.05 | 0.26 | 0.11 |
PB Ratio | 0.04 | 0.05 | 0.03 | 0.01 | 0.07 | 0.07 |
P/TBV Ratio | 0.05 | 0.06 | 0.04 | 0.01 | 0.09 | 0.09 |
P/FCF Ratio | 7.10 | 9.49 | 0.63 | 0.29 | 2.47 | 0.27 |
P/OCF Ratio | 5.06 | 6.76 | 0.63 | 0.25 | 1.69 | 0.25 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 25.63 | 24.25 | 9.31 | 9.46 | 6.35 | 2.40 |
EV/EBITDA Ratio | - | - | 78.59 | - | - | 40.89 |
EV/EBIT Ratio | - | - | 102.14 | - | - | 47.93 |
EV/FCF Ratio | 496.75 | 469.92 | 37.15 | 52.44 | 59.93 | 5.85 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.25 | 2.25 | 1.84 | 1.61 | 1.48 | 1.36 |
Debt / EBITDA Ratio | - | - | 69.57 | - | - | 35.58 |
Debt / FCF Ratio | 445.68 | 445.68 | 33.60 | 49.05 | 51.40 | 5.15 |
Net Debt / Equity Ratio | 2.23 | 2.23 | 1.83 | 1.60 | 1.47 | 1.32 |
Net Debt / EBITDA Ratio | -43.60 | -43.60 | 70.58 | -57.23 | -64.62 | 35.06 |
Net Debt / FCF Ratio | 442.97 | 442.97 | 33.37 | 48.71 | 50.94 | 5.01 |
Asset Turnover | 0.02 | 0.02 | 0.05 | 0.04 | 0.07 | 0.15 |
Inventory Turnover | 0.07 | 0.07 | 0.10 | 0.11 | 0.15 | 0.30 |
Quick Ratio | 0.27 | 0.27 | 0.33 | 0.23 | 0.19 | 0.23 |
Current Ratio | 1.00 | 1.00 | 1.03 | 1.00 | 1.00 | 1.19 |
Return on Equity (ROE) | -15.41% | -15.41% | -10.82% | -4.21% | -6.68% | 2.26% |
Return on Assets (ROA) | -0.66% | -0.66% | 0.27% | -0.51% | -0.44% | 0.48% |
Return on Invested Capital (ROIC) | -1.71% | -1.70% | 0.70% | -1.29% | -1.17% | 0.53% |
Return on Capital Employed (ROCE) | -2.30% | -2.30% | 1.00% | -1.70% | -1.60% | 1.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -480.33% | -359.31% | -291.19% | -436.86% | -89.30% | 20.68% |
FCF Yield | 14.08% | 10.54% | 159.22% | 350.21% | 40.45% | 368.16% |